Stryker (SYK) Total Non-Current Liabilities (2009 - 2026)
Stryker's (SYK) quarterly Total Non-Current Liabilities came in at $21.3 billion in Q2 2026, down 5.46% year-over-year from $22.5 billion in Q2 2025, and up 1.62% quarter-over-quarter from $20.9 billion in Q1 2026.
Analysis
Stryker (SYK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Total Non-Current Liabilities for 18 consecutive years, with $21.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 5.46% year-over-year to $21.3 billion in Q2 2026; TTM through Jun 2026 was $21.3 billion, a 5.46% decrease from a year earlier, with the FY2025 full-year figure at $23.1 billion, up 14.4% from the prior year.
- Total Non-Current Liabilities was $21.3 billion for Q2 2026 at Stryker, up from $20.9 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $23.1 billion in Q4 2025 and troughed at $17.4 billion in Q2 2024.
- A 5-year average of $20.0 billion and a median of $19.3 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities advanced 29.36% in 2025 and fell 7.68% in 2026, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $18.8 billion in 2022, then increased by 3.13% to $19.4 billion in 2023, then climbed by 3.94% to $20.2 billion in 2024, then climbed by 14.4% to $23.1 billion in 2025, then dropped by 7.69% to $21.3 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $21.3 billion (Q2 2026), $20.9 billion (Q1 2026), and $23.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.28 Bn |
| Mar 31, 2026 | 20.94 Bn |
| Dec 31, 2025 | 23.06 Bn |
| Sep 30, 2025 | 22.66 Bn |
| Jun 30, 2025 | 22.51 Bn |
| Mar 31, 2025 | 22.68 Bn |
| Dec 31, 2024 | 20.15 Bn |
| Sep 30, 2024 | 21.36 Bn |
| Jun 30, 2024 | 17.40 Bn |
| Mar 31, 2024 | 18.33 Bn |
| Dec 31, 2023 | 19.39 Bn |
| Sep 30, 2023 | 18.31 Bn |
| Jun 30, 2023 | 18.20 Bn |
| Mar 31, 2023 | 18.35 Bn |
| Dec 31, 2022 | 18.80 Bn |
| Sep 30, 2022 | 17.94 Bn |
| Jun 30, 2022 | 18.57 Bn |
| Mar 31, 2022 | 19.21 Bn |
| Dec 31, 2021 | 17.93 Bn |
| Sep 30, 2021 | 18.01 Bn |